Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) is one of 137 public companies in the “Beverages” industry, but how does it contrast to its rivals? We will compare Arcadia Biosciences to related businesses based on the strength of its institutional ownership, analyst recommendations, earnings, valuation, risk, dividends and profitability.
Insider & Institutional Ownership
17.7% of Arcadia Biosciences shares are held by institutional investors. Comparatively, 36.3% of shares of all “Beverages” companies are held by institutional investors. 4.5% of Arcadia Biosciences shares are held by company insiders. Comparatively, 19.4% of shares of all “Beverages” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Arcadia Biosciences and its rivals revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Arcadia Biosciences | $4.86 million | -$2.34 million | -0.03 |
| Arcadia Biosciences Competitors | $8.49 billion | $869.16 million | 5.46 |
Profitability
This table compares Arcadia Biosciences and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Arcadia Biosciences | -202.09% | -203.20% | -90.95% |
| Arcadia Biosciences Competitors | -7.33% | -29.46% | 0.32% |
Volatility & Risk
Arcadia Biosciences has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, Arcadia Biosciences’ rivals have a beta of -0.24, indicating that their average share price is 124% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings for Arcadia Biosciences and its rivals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Arcadia Biosciences | 1 | 0 | 0 | 0 | 1.00 |
| Arcadia Biosciences Competitors | 1293 | 4349 | 5802 | 234 | 2.43 |
As a group, “Beverages” companies have a potential upside of 9.91%. Given Arcadia Biosciences’ rivals stronger consensus rating and higher probable upside, analysts clearly believe Arcadia Biosciences has less favorable growth aspects than its rivals.
Summary
Arcadia Biosciences rivals beat Arcadia Biosciences on 12 of the 13 factors compared.
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc. is an agricultural biotechnology and food company focused on developing and commercializing plant-based products. The company has historically used plant breeding and biotechnology to develop crop traits, including traits intended to improve crop performance and the nutritional qualities of food. Its consumer-facing GoodWheat brand is built around wheat varieties bred for higher fiber and protein content. Products have included wheat flour, pasta and crackers, which are marketed to consumers seeking more nutritious options made with familiar grain ingredients.
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
